Aspen is giving up on local lenacapavir production because demand isn’t guaranteed. Instead, the company is supporting Merck’s alimatravir pill as a means of preventing HIV. Aspen Pharmacare has walked away from government plans to produce lenacapavir locally. This is the clearest sign yet that South Africa’s bid to make its own HIV prevention injection faces stiff commercial headwinds. Instead,…